Works by Orlowski, Robert Z.

Results: 139
    1

    Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.

    Published in:
    2020
    By:
    • Danziger, Samuel A.;
    • McConnell, Mark;
    • Gockley, Jake;
    • Young, Mary H.;
    • Rosenthal, Adam;
    • Schmitz, Frank;
    • Reiss, David J.;
    • Farmer, Phil;
    • Alapat, Daisy V.;
    • Singh, Amrit;
    • Ashby, Cody;
    • Bauer, Michael;
    • Ren, Yan;
    • Smith, Kelsie;
    • Couto, Suzana S.;
    • van Rhee, Frits;
    • Davies, Faith;
    • Zangari, Maurizio;
    • Petty, Nathan;
    • Orlowski, Robert Z.
    Publication type:
    journal article
    2

    Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
    By:
    • Zangari, Maurizio;
    • Aujay, Monette;
    • Fenghuang Zhan;
    • Hetherington, Kristina L.;
    • Berno, Tamara;
    • Vij, Ravi;
    • Jagannath, Sundar;
    • Siegel, David;
    • Stewart, A. Keith;
    • Wang, Luhua;
    • Orlowski, Robert Z.;
    • Belch, Andrew;
    • Jakubowiak, Andrzej;
    • Somlo, George;
    • Trudel, Suzanne;
    • Bahlis, Nizar;
    • Lonial, Sagar;
    • Singhal, Seema;
    • Kukreti, Vishal;
    • Tricot, Guido
    Publication type:
    Article
    3
    4
    5
    6

    Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1746, doi. 10.1002/ajh.27382
    By:
    • Delimpasi, Sosana;
    • Dimopoulos, Meletios A.;
    • Straub, Jan;
    • Symeonidis, Argiris;
    • Pour, Luděk;
    • Hájek, Roman;
    • Touzeau, Cyrille;
    • Bhanderi, Viralkumar K.;
    • Berdeja, Jesus G.;
    • Pavlíček, Petr;
    • Matous, Jeffrey V.;
    • Robak, Pawel J.;
    • Suryanarayan, Kaveri;
    • Miller, Alison;
    • Villarreal, Miguel;
    • Cherepanov, Dasha;
    • Srimani, Jaydeep K.;
    • Yao, Huilan;
    • Labotka, Richard;
    • Orlowski, Robert Z.
    Publication type:
    Article
    7

    Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
    By:
    • Silbermann, Rebecca;
    • Laubach, Jacob;
    • Kaufman, Jonathan L.;
    • Sborov, Douglas W.;
    • Reeves, Brandi;
    • Rodriguez, Cesar;
    • Chari, Ajai;
    • Costa, Luciano J.;
    • Anderson, Larry D.;
    • Nathwani, Nitya;
    • Shah, Nina;
    • Bumma, Naresh;
    • Holstein, Sarah A.;
    • Costello, Caitlin;
    • Jakubowiak, Andrzej;
    • Orlowski, Robert Z.;
    • Shain, Kenneth H.;
    • Cowan, Andrew J.;
    • Gries, Katharine S.;
    • Pei, Huiling
    Publication type:
    Article
    8

    Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Sami, Sophiya S.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Saeed, Arsalan;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.
    Publication type:
    Article
    9

    Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
    By:
    • Patel, Romil;
    • Ma, Junsheng;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday R.;
    • Hosing, Chitra M.;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Alousi, Amin M.;
    • Daher, May;
    • Mehta, Rohtesh;
    • Srour, Samer;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth S.;
    • Champlin, Richard E.
    Publication type:
    Article
    10
    11
    12
    13

    Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
    By:
    • Saini, Neeraj Y.;
    • Patel, Romil D.;
    • Varma, Ankur;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday;
    • Hosing, Chitra;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.;
    • Patel, Krina K.
    Publication type:
    Article
    14

    Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
    By:
    • Saini, Neeraj Y.;
    • Patel, Romil;
    • Varma, Ankur;
    • Bashir, Qaiser;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Popat, Uday R.;
    • Hosing, Chitra M.;
    • Nieto, Yago;
    • Kebriaei, Partow;
    • Alousi, Amin M.;
    • Ahmed, Sairah;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Lee, Hans C.;
    • Manasanch, Elisabet E.;
    • Patel, Krina K.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    15

    Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 10, p. E442, doi. 10.1002/ajh.24487
    By:
    • Gaballa, Sameh;
    • Saliba, Rima M.;
    • Srour, Samer;
    • Lu, Gary;
    • Brammer, Jonathan E.;
    • Shah, Nina;
    • Bashir, Qaiser;
    • Patel, Krina;
    • Bock, Fabian;
    • Parmar, Simrit;
    • Hosing, Chitra;
    • Popat, Uday;
    • Delgado, Ruby;
    • Rondon, Gabriela;
    • Shah, Jatin J.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    16

    A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 1, p. 42, doi. 10.1002/ajh.23868
    By:
    • Orlowski, Robert Z.;
    • Gercheva, Liana;
    • Williams, Cathy;
    • Sutherland, Heather;
    • Robak, Tadeusz;
    • Masszi, Tamás;
    • Goranova-Marinova, Vesselina;
    • Dimopoulos, Meletios A.;
    • Cavenagh, James D.;
    • Špička, Ivan;
    • Maiolino, Angelo;
    • Suvorov, Alexander;
    • Bladé, Joan;
    • Samoylova, Olga;
    • Puchalski, Thomas A.;
    • Reddy, Manjula;
    • Bandekar, Rajesh;
    • van de Velde, Helgi;
    • Xie, Hong;
    • Rossi, Jean-Franςois
    Publication type:
    Article
    17

    Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 3, p. 272, doi. 10.1002/ajh.22273
    By:
    • Bashir, Qaiser;
    • Khan, Hassan;
    • Orlowski, Robert Z.;
    • Amjad, Ali Imran;
    • Shah, Nina;
    • Parmar, Simrit;
    • Wei, Wei;
    • Rondon, Gabriela;
    • Weber, Donna M.;
    • Wang, Michael;
    • Thomas, Sheeba K.;
    • Shah, Jatin J.;
    • Qureshi, Sofia R.;
    • Dinh, Yvonne T.;
    • Popat, Uday;
    • Anderlini, Paolo;
    • Hosing, Chitra;
    • Giralt, Sergio;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    18

    Once‐weekly (70 mg/m<sup>2</sup>) vs twice‐weekly (56 mg/m<sup>2</sup>) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION‐1 trials.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 9, p. 2989, doi. 10.1002/cam4.2945
    By:
    • Moreau, Philippe;
    • Stewart, Keith A.;
    • Dimopoulos, Meletios;
    • Siegel, David;
    • Facon, Thierry;
    • Berenson, James;
    • Raje, Noopur;
    • Berdeja, Jesus G.;
    • Orlowski, Robert Z.;
    • Yang, Hui;
    • Ma, Haijun;
    • Klippel, Zandra;
    • Zahlten‐Kumeli, Anita;
    • Mezzi, Khalid;
    • Iskander, Karim;
    • Mateos, Maria‐Victoria
    Publication type:
    Article
    19
    20

    Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Pal, Babar;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Lee, Jaehyun;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Becnel, Melody R.;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    21

    Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
    By:
    • Pasvolsky, Oren;
    • Wang, Zhongya;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Kebriaei, Partow;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Lee, Hans C.;
    • Ye, Christine;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    22

    Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
    By:
    • Chari, Ajai;
    • Kaufman, Jonathan L.;
    • Laubach, Jacob;
    • Sborov, Douglas W.;
    • Reeves, Brandi;
    • Rodriguez, Cesar;
    • Silbermann, Rebecca;
    • Costa, Luciano J.;
    • Anderson Jr, Larry D.;
    • Nathwani, Nitya;
    • Shah, Nina;
    • Bumma, Naresh;
    • Holstein, Sarah A.;
    • Costello, Caitlin;
    • Jakubowiak, Andrzej;
    • Wildes, Tanya M.;
    • Orlowski, Robert Z.;
    • Shain, Kenneth H.;
    • Cowan, Andrew J.;
    • Pei, Huiling
    Publication type:
    Article
    23

    Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
    By:
    • Pasvolsky, Oren;
    • Wang, Zhongya;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Kebriaei, Partow;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Lee, Hans C.;
    • Ye, Christine;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    24
    25

    Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
    By:
    • Pasvolsky, Oren;
    • Ghanem, Sassine;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Khan, Hina N.;
    • Kebriaei, Partow;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    26

    Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Ghanem, Sassine;
    • Masood, Adeel;
    • Mohamedi, Ali H.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    27

    Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
    By:
    • Pasvolsky, Oren;
    • Milton, Denái R.;
    • Rauf, Mikael;
    • Ghanem, Sassine;
    • Masood, Adeel;
    • Mohamedi, Ali H.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    28

    Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4
    By:
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • White, Darrell;
    • Moreau, Philippe;
    • Weisel, Katja;
    • San-Miguel, Jesus;
    • Shpilberg, Ofer;
    • Grosicki, Sebastian;
    • Špička, Ivan;
    • Walter-Croneck, Adam;
    • Magen, Hila;
    • Mateos, Maria-Victoria;
    • Belch, Andrew;
    • Reece, Donna;
    • Beksac, Meral;
    • Spencer, Andrew;
    • Oakervee, Heather;
    • Orlowski, Robert Z.;
    • Taniwaki, Masafumi;
    • Röllig, Christoph
    Publication type:
    Article
    29

    Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0311-8
    By:
    • Durie, Brian G. M.;
    • Hoering, Antje;
    • Sexton, Rachael;
    • Abidi, Muneer H.;
    • Epstein, Joshua;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela;
    • Kahanic, Stephen P.;
    • Thakuri, Mohan C.;
    • Reu, Frederic J.;
    • Reynolds, Christopher M.;
    • Orlowski, Robert Z.;
    • Barlogie, Bart
    Publication type:
    Article
    30

    Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0273-x
    By:
    • Dimopoulos, Meletios A.;
    • Jakubowiak, Andrzej J.;
    • McCarthy, Philip L.;
    • Orlowski, Robert Z.;
    • Attal, Michel;
    • Bladé, Joan;
    • Goldschmidt, Hartmut;
    • Weisel, Katja C.;
    • Ramasamy, Karthik;
    • Zweegman, Sonja;
    • Spencer, Andrew;
    • Huang, Jeffrey S. Y.;
    • Lu, Jin;
    • Sunami, Kazutaka;
    • Iida, Shinsuke;
    • Chng, Wee-Joo;
    • Holstein, Sarah A.;
    • Rocci, Alberto;
    • Skacel, Tomas;
    • Labotka, Richard
    Publication type:
    Article
    31
    32

    Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 1, p. 118, doi. 10.3109/10428194.2011.606942
    By:
    • Bashir, Qaiser;
    • Shah, Nina;
    • Parmar, Simrit;
    • Wei, Wei;
    • Rondon, Gabriela;
    • Weber, Donna M.;
    • Wang, Michael;
    • Orlowski, Robert Z.;
    • Thomas, Sheeba K.;
    • Shah, Jatin;
    • Qureshi, Sofia R.;
    • Dinh, Yvonne T.;
    • Popat, Uday;
    • Anderlini, Paolo;
    • Hosing, Chitra;
    • Giralt, Sergio;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    33
    34
    35
    36
    37

    P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY‐RELATED CLONAL HEMATOPOIESIS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972208.18169.8b
    By:
    • Uryu, Hidetaka;
    • Saeki, Koichi;
    • Nangalia, Jyoti;
    • Chapman, Michael;
    • Zhao, LI;
    • Hsu, Joanne;
    • Bueso‐Ramos, Carlos;
    • Chen, Shujuan;
    • Yang, Hui;
    • Dinardo, Courtney;
    • Daver, Naval;
    • Colla, Simona;
    • Ganan‐Gomez, Irene;
    • Zhang, Jianhua;
    • Song, Xingzhi;
    • Thompson, Erika;
    • Tang, Hongli;
    • Orlowski, Robert Z;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    38

    P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH‐RISK CYTOGENETIC ABNORMALITIES.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972004.30708.e8
    By:
    • Pasvolsky, Oren;
    • Ghanem, Sassine;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Ramdial, Jeremy L.;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    39

    P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE‐EXPANSION PHASE OF THE CC‐92480‐MM‐001 TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970376.71405.63
    By:
    • Bahlis, Nizar J;
    • Trudel, Suzanne;
    • Quach, Hang;
    • Popat, Rakesh;
    • Lonial, Sagar;
    • Orlowski, Robert Z;
    • Kim, Kihyun;
    • Mateos, Maria‐Victoria;
    • Pawlyn, Charlotte;
    • Ramasamy, Karthik;
    • Martinez‐Lopez, Joaquín;
    • Casas‐Avilés, Ignacio;
    • Spirli, Alessia;
    • Gong, Jing;
    • Amatangelo, Michael;
    • Katz, Jessica;
    • Maciag, Paulo;
    • Peluso, Teresa;
    • Richardson, Paul
    Publication type:
    Article
    40
    41

    P1299: OUTCOMES OF YOUNG ADULTS (AGED ≤40 YEARS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANT.

    Published in:
    2023
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Masood, Adeel;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Ramdial, Jeremy L.;
    • Nieto, Yago;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Kebriaei, Partow;
    • Tewari, Priti;
    • Thomas, Sheeba K.;
    • Weber, Donna M.;
    • Orlowski, Robert Z.;
    • Crawford-Suber, Lindsay;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.
    Publication type:
    Abstract
    42

    SARS-CoV-2 in multiple myeloma: initial observation and management.

    Published in:
    2020
    By:
    • Manasanch, Elisabet E.;
    • Mulanovich, Victor;
    • Manzano, Joanna-Grace;
    • Gaeta, Maria Susan;
    • Becnel, Melody;
    • Kaufman, Gregory P.;
    • Lee, Hans C.;
    • Amini, Behrang;
    • Thomas, Sheeba K.;
    • Iyer, Swaminathan P.;
    • Weber, Donna M.;
    • Berkova, Zuzana;
    • Flowers, Christopher R.;
    • Orlowski, Robert Z.;
    • Patel, Krina K.
    Publication type:
    Letter
    43

    Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 14, p. 3536, doi. 10.1080/10428194.2019.1633633
    By:
    • Bashir, Qaiser;
    • Chamoun, Kamal;
    • Milton, Denái R.;
    • Khan, Maliha;
    • Ahmed, Sairah;
    • Mehta, Rohtesh;
    • Popat, Uday R.;
    • Kebriaei, Partow;
    • Nieto, Yago;
    • Oran, Betul;
    • Ciurea, Stefan O.;
    • Hosing, Chitra;
    • Khouri, Isa;
    • Patel, Krina;
    • Manasanch, Elisabet E.;
    • Lee, Hans C.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Article
    44

    High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 2, p. 442, doi. 10.1080/10428194.2018.1485908
    By:
    • Hu, Bei;
    • Thall, Peter;
    • Milton, Denái R;
    • Sasaki, Koji;
    • Bashir, Qaiser;
    • Shah, Nina;
    • Popat, Uday;
    • Hosing, Chitra;
    • Nieto, Yago;
    • Delgado, Ruby;
    • Champlin, Richard;
    • Qazilbash, Muzaffar H.;
    • Patel, Krina;
    • Manasanch, Elisabet;
    • Weber, Donna;
    • Thomas, Sheeba;
    • Orlowski, Robert Z.;
    • Lin, Pei;
    • Jorgensen, Jeffrey
    Publication type:
    Article
    45
    46

    A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.

    Published in:
    2018
    By:
    • Mohyuddin, Ghulam Rehman;
    • Faisal, Muhammad Salman;
    • Badar, Talha;
    • Shah, Nina;
    • Bashir, Qaiser;
    • Patel, Krina K.;
    • Hosing, Chitra;
    • Popat, Uday R.;
    • Rondon, Gabriela;
    • Delgado, Ruby;
    • Shah, Jatin J.;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Letter to the Editor
    47
    48
    49
    50